Todos Medical Ltd. (TOMDF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2022 | -9.39 Million USD | -24.01% |
| 2021 | -9.71 Million USD | 70.08% |
| 2020 | -14.16 Million USD | -173.91% |
| 2019 | -7.78 Million USD | -280.81% |
| 2018 | -1.35 Million USD | -76.98% |
| 2017 | -1.31 Million USD | -85.48% |
| 2016 | -708.19 Thousand USD | 13.54% |
| 2015 | -819.08 Thousand USD | -104.56% |
| 2014 | -400.41 Thousand USD | -18.03% |
| 2013 | -339.25 Thousand USD | -138815.48% |
| 2012 | -244.22 USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2023 Q1 | - USD | 100.0% |
| 2022 Q4 | -1.88 Million USD | -5.39% |
| 2022 Q2 | -2.05 Million USD | -543.26% |
| 2022 FY | - USD | -24.01% |
| 2022 Q1 | -319.54 Thousand USD | 91.68% |
| 2022 Q3 | -1.78 Million USD | 13.11% |
| 2021 Q1 | -13.39 Million USD | -46.4% |
| 2021 FY | - USD | 70.08% |
| 2021 Q4 | -3.84 Million USD | 10.27% |
| 2021 Q3 | -4.28 Million USD | -192.55% |
| 2021 Q2 | -1.46 Million USD | 89.07% |
| 2020 Q1 | -3.12 Million USD | 0.0% |
| 2020 FY | - USD | -173.91% |
| 2020 Q4 | -9.14 Million USD | -59.75% |
| 2020 Q3 | -5.72 Million USD | -234.33% |
| 2020 Q2 | -1.71 Million USD | 45.22% |
| 2019 FY | - USD | -280.81% |
| 2018 FY | - USD | -76.98% |
| 2017 FY | - USD | -85.48% |
| 2016 FY | - USD | 13.54% |
| 2015 Q4 | -142.39 Thousand USD | 0.0% |
| 2015 Q3 | -142.39 Thousand USD | 46.7% |
| 2015 Q2 | -267.14 Thousand USD | 0.0% |
| 2015 Q1 | -267.14 Thousand USD | -159.94% |
| 2015 FY | - USD | -104.56% |
| 2014 Q1 | -97.43 Thousand USD | 0.0% |
| 2014 Q4 | -102.77 Thousand USD | -0.0% |
| 2014 Q2 | -97.43 Thousand USD | 0.0% |
| 2014 FY | - USD | -18.03% |
| 2014 Q3 | -102.77 Thousand USD | -5.48% |
| 2013 FY | - USD | -138815.48% |
| 2012 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Bio Medica Corporation | -1.16 Million USD | -707.739% |
| Arrayit Corporation | -3.07 Million USD | -205.248% |
| Atlantic International Corp. | -5.38 Million USD | -74.3% |
| Biocept, Inc. | -30.24 Million USD | 68.936% |
| Bioqual, Inc. | 3.03 Million USD | 409.804% |
| CardioGenics Holdings Inc | -757.37 Thousand USD | -1140.337% |
| DermTech, Inc. | -97.89 Million USD | 90.404% |
| Global WholeHealth Partners Corporation | - USD | Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.322% |
| HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 53.593% |
| iMD Companies, Inc. | -154.65 Thousand USD | -5974.008% |
| IDenta Corp. | 71.58 Thousand USD | 13222.494% |
| Interpace Biosciences, Inc. | 3.83 Million USD | 344.827% |
| Integrative Health Technologies, Inc. | 38.69 Thousand USD | 24380.176% |
| InVitro International | 6680.00 USD | 140728.743% |
| Lumos Diagnostics Holdings Limited | -5.43 Million USD | -72.811% |
| Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -77318.823% |
| Medical Imaging Corp. | -896.74 Thousand USD | -947.57% |
| NovelStem International Corp. | -3.78 Million USD | -148.138% |
| Optigenex Inc. | -1.18 Million USD | -691.591% |
| PharmChem, Inc. | 1.05 Million USD | 991.432% |
| Proteome Sciences plc | -1.13 Million USD | -726.209% |
| Response Genetics, Inc | -19.66 Million USD | 52.232% |
| Rennova Health, Inc. | -234.81 Thousand USD | -3900.596% |
| RushNet, Inc. | -614.85 Thousand USD | -1427.847% |
| ScreenPro Security Inc. | -3.43 Million USD | -173.488% |
| Stella Diagnostics Inc. | -5.7 Million USD | -64.592% |
| StageZero Life Sciences Ltd. | -10.27 Million USD | 8.531% |